Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Inflammatory Bowel Diseases

  Free Subscription

Articles published in Z Gastroenterol

Retrieve available abstracts of 47 articles:
HTML format

Single Articles

    June 2021
  1. MULLER A, Bilger SS, Goldi A, Meinlschmidt G, et al
    [The IBD-Control questionnaire: German translation and validation of the standardized questionnaire for Patient Reported Outcome Measurement in inflammatory bowel disease].
    Z Gastroenterol. 2021 Jun 24. doi: 10.1055/a-1482-8642.
    PubMed     Abstract available

    Steroid-refractory ulcerative colitis: a critical review of national and international guideline recommendations.
    Z Gastroenterol. 2021 Jun 23. doi: 10.1055/a-1482-9273.
    PubMed     Abstract available

  3. NEUFELD T, Pfuhlmann K, Stock-Schroer B, Kairey L, et al
    Cannabis use of patients with inflammatory bowel disease in Germany: a cross-sectional survey.
    Z Gastroenterol. 2021 Jun 22. doi: 10.1055/a-1400-2768.
    PubMed     Abstract available

    May 2021

  4. Z Gastroenterol. 2021;59:479.

    April 2021
  5. HAZIRI D, Prechter F, Stallmach A
    [Yoghurt-induced Lactobacillus bacteremia in a patient with Crohn's disease on therapy with ustekinumab and concomitant HIV-Infection].
    Z Gastroenterol. 2021;59:317-320.
    PubMed     Abstract available

    March 2021
  6. WALLDORF J, Pijan E, Greinert R, Riesner-Wehner A, et al
    Family planning with inflammatory bowel disease: the challenge of childlessness and parent concerns.
    Z Gastroenterol. 2021 Mar 18. doi: 10.1055/a-1404-3610.
    PubMed     Abstract available

    December 2020
  7. KONIG P, Jimenez K, Saletu-Zyhlarz G, Mittlbock M, et al
    Iron deficiency, depression, and fatigue in inflammatory bowel diseases.
    Z Gastroenterol. 2020;58:1191-1200.
    PubMed     Abstract available

  8. LYNEN P, Dignass A, Kucharzik T, Siegmund B, et al

    Z Gastroenterol. 2020;58:1208.

  9. VAN LEEUWEN P, Dignass A, Kucharzik T, Jansen PL, et al

    Z Gastroenterol. 2020;58:e346-e351.

  10. KUCHARZIK T, Dignass A, Siegmund B

    Z Gastroenterol. 2020;58:1209-1232.

  11. KUCHARZIK T, Dignass AU, Atreya R, Bokemeyer B, et al

    Z Gastroenterol. 2020;58:e241-e326.

    November 2020
  12. LI Z, Qiao L, Yun X, Du F, et al
    Increased risk of ischemic heart disease and diabetes in inflammatory bowel disease.
    Z Gastroenterol. 2020 Nov 24. doi: 10.1055/a-1283-6966.
    PubMed     Abstract available

    October 2020
  13. STALLMACH A, Sturm A, Blumenstein I, Helwig U, et al
    Addendum to S3-Guidelines Crohn's disease and ulcerative colitis: Management of Patients with Inflammatory Bowel Disease in the COVID-19 Pandemic - open questions and answers.
    Z Gastroenterol. 2020;58:982-1002.
    PubMed     Abstract available

    September 2020
  14. DE LAFFOLIE J, Schwerd T, Simon A, Pauli M, et al
    [Crohn's Disease Exclusion Diet - an alternative to exlusive enteral nutritional therapy in children and adolescents with Crohn's disease? Statement of the GPGE working groups CEDATA and Nutrition/Nutrition Medicine].
    Z Gastroenterol. 2020;58:890-894.
    PubMed     Abstract available

  15. STORKMANN H, Rodel J, Stallmach A, Reuken PA, et al
    Are CMV-predictive scores in inflammatory bowel disease useful in clinical practice?
    Z Gastroenterol. 2020;58:868-871.
    PubMed     Abstract available

    August 2020
  16. SCHNORBACH MT, Kruis W
    [Cost of illness of inflammatory bowel disease in Germany].
    Z Gastroenterol. 2020 Aug 31. doi: 10.1055/a-1174-0670.
    PubMed     Abstract available

    July 2020

  17. [Addendum to S3-Guidelines Crohn's disease and ulcerative colitis: Management of Patients with Inflammatory Bowel Disease in the COVID-19 Pandemic - open questions and answers].
    Z Gastroenterol. 2020;58:672-692.

  18. STALLMACH A, Sturm A, Blumenstein I, Helwig U, et al
    [Addendum to S3-Guidelines Crohn's disease and ulcerative colitis: Management of Patients with Inflammatory Bowel Disease in the COVID-19 Pandemic - open questions and answers].
    Z Gastroenterol. 2020;58:e367.

    May 2020
  19. THOMANN AK, Schulte LA, Globig AM, Hoffmann P, et al
    Ustekinumab serum concentrations are associated with clinical outcomes in Crohn's disease - a regional multi-center pilot study.
    Z Gastroenterol. 2020;58:439-444.
    PubMed     Abstract available

    February 2020
  20. KELLER R, Fusco S, Stange EF, Malek NP, et al
    Infodemiology of Crohn's disease and Ulcerative colitis using Google Trends - an approach to investigate patient needs.
    Z Gastroenterol. 2020 Feb 4. doi: 10.1055/a-1068-2877.
    PubMed     Abstract available

    [IL-7 receptor influences anti-TNF responsiveness and T cell gut homing in inflammatory bowel disease].
    Z Gastroenterol. 2020;58:171.

    December 2019
  22. HELWIG U
    [Appendicectomy prior to colectomy in ulcerative colitis?]
    Z Gastroenterol. 2019;57:1514.

    November 2019
  23. SCHULTE LA, Schafer A, Steding K, Rauschek L, et al
    [Acceptance of fecal microbiota transfer among patients with chronic inflammatory bowel diseases in a highly specialized outpatient department: a questionnaire-based survey].
    Z Gastroenterol. 2019;57:1291-1297.
    PubMed     Abstract available

    October 2019
  24. GORENJAK M, Repnik K, Jezernik G, Jurgec S, et al
    Genetic prediction profile for adalimumab response in Slovenian Crohn's disease patients.
    Z Gastroenterol. 2019;57:1218-1225.
    PubMed     Abstract available

    July 2019
  25. BRANDES A, Groth A, Gottschalk F, Wilke T, et al
    Real-world biologic treatment and associated cost in patients with inflammatory bowel disease.
    Z Gastroenterol. 2019;57:843-851.
    PubMed     Abstract available

    May 2019
  26. GEORGIADOU E, Fanter L, Brandes A, Ratsch BA, et al
    Perianal fistulas in adult patients with Crohn's disease in Germany - a retrospective cross-sectional analysis of claims data from German sickness funds.
    Z Gastroenterol. 2019;57:574-583.
    PubMed     Abstract available

    April 2019
  27. STALLMACH A, Grunert P, Pieper D, Steube A, et al
    [Ulcerative colitis: Does the modulation of gut microbiota induce long-lasting remission?]
    Z Gastroenterol. 2019 Apr 15. doi: 10.1055/a-0874-6603.
    PubMed     Abstract available

  28. PETRUO VA, Krauss E, Kleist A, Hardt J, et al
    Perceived distress, personality characteristics, coping strategies and psychosocial impairments in a national German multicenter cohort of patients with Crohn's disease and ulcerative colitis.
    Z Gastroenterol. 2019;57:473-483.
    PubMed     Abstract available

    March 2019
  29. ROGGENBROD S, Schuler C, Haller B, Sohn M, et al
    [Patient perception and approval of fecal microbiota transplantation (FMT) as an alternative treatment option for ulcerative colitis].
    Z Gastroenterol. 2019;57:296-303.
    PubMed     Abstract available

    January 2019

  30. Updated S3-Guideline Ulcerative Colitis. German Society for Digestive and Metabolic Diseases (DGVS).
    Z Gastroenterol. 2019 Jan 17. doi: 10.1055/a-0824-0861.
    PubMed     Abstract available

  31. KOSCHNY R, Allgauer M, Pfeiffenberger J, Seessle J, et al
    Case report: a rare cause of a hypervascular nodule in a noncirrhotic liver.
    Z Gastroenterol. 2019;57:57-60.
    PubMed     Abstract available

    November 2018
  32. METZGER JC, Kurz E, von Spee-Mayer C, Kolck G, et al
    [Chronic granulomatous disease as a rare differential diagnosis of inflammatory bowel disease].
    Z Gastroenterol. 2018 Nov 22. doi: 10.1055/a-0732-5865.
    PubMed     Abstract available

  33. STALLMACH A, Reuken PA, Teich N
    [Advances in the diagnosis and treatment of Clostridioides [Clostridium] difficile infections in inflammatory bowel disease].
    Z Gastroenterol. 2018;56:1369-1377.
    PubMed     Abstract available

    May 2018
  34. HUPPE A, Langbrandtner J, Hauser W, Raspe H, et al
    Validation of the "German Inflammatory Bowel Disease Activity Index (GIBDI)": An Instrument for Patient-Based Disease Activity Assessment in Crohn's Disease and Ulcerative Colitis.
    Z Gastroenterol. 2018 May 9. doi: 10.1055/a-0605-4080.
    PubMed     Abstract available

  35. SCHNEIDER A, Hirth M, Weiss C, Weidner P, et al
    Prevalence of inflammatory bowel disease in alcoholic, non-alcoholic and autoimmune pancreatitis.
    Z Gastroenterol. 2018;56:469-478.
    PubMed     Abstract available

    February 2018
  36. STALLMACH A, Anttila VJ, Hell M, Gwynn S, et al
    Inflammatory bowel disease and Clostridium difficile infection: contrasting views of international clinical professionals.
    Z Gastroenterol. 2018 Feb 9. doi: 10.1055/s-0044-100045.
    PubMed     Abstract available

  37. NOWACKI TM, Bettenworth D
    [When to operate Crohn's disease patients with ileocaecal manifestation ?]
    Z Gastroenterol. 2018;56:165-167.

    December 2017
  38. MOGL MT, Baumgart DC, Fischer A, Pratschke J, et al
    Immunosuppression following liver transplantation and the course of inflammatory bowel disease - a case control study.
    Z Gastroenterol. 2017 Dec 6. doi: 10.1055/s-0043-117183.
    PubMed     Abstract available

    August 2017
  39. REINSHAGEN M, Stallmach A
    [Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial].
    Z Gastroenterol. 2017;55:779-780.

    June 2017
  40. MONASTERIO C, Schmitt-Graff A, Pohl M, Truschel T, et al
    Fatal ulcerative enteritis of the small intestine in a patient with ulcerative colitis treated with vedolizumab.
    Z Gastroenterol. 2017 Jun 27. doi: 10.1055/s-0043-111805.
    PubMed     Abstract available

    January 2017
  41. BOKEMEYER B, Dignass A, Schreiber S
    [Biosimilars in Inflammatory Bowel Disease (IBD): Experiences and perceptions of german gastroenterologists].
    Z Gastroenterol. 2017 Jan 5. doi: 10.1055/s-0042-121520.
    PubMed     Abstract available

  42. HELWIG U
    [Relapse after withdrawal from anti-TNF therapy for inflammatory bowel disease].
    Z Gastroenterol. 2017;55:85.

    December 2016
    [Evolution of clinical trial design investigating biological therapies in patients with inflammatory bowel disease - implications for clinical practic].
    Z Gastroenterol. 2016.

    October 2016
  44. SIEGMUND B, Atreya R, Bokemeyer B, Kruis W, et al
    [Biosimilars in inflammatory bowel disease].
    Z Gastroenterol. 2016.
    PubMed     Abstract available

  45. GEHRMANN U, Berger U, Teich N, Bruns T, et al
    Motivation of patients with inflammatory bowel disease to participate in a clinical trial.
    Z Gastroenterol. 2016;54:1123-1129.
    PubMed     Abstract available

    September 2016
  46. RUDDEL J, Schleenvoigt BT, Schuler E, Schmidt C, et al
    Yellow fever vaccination during treatment with infliximab in a patient with ulcerative colitis: A case report.
    Z Gastroenterol. 2016;54:1081-4.
    PubMed     Abstract available

    February 2016
  47. LANGBRANDTNER J, Raspe H, Huppe A
    [Employees with chronic diseases - additional results of randomized controlled trial among adult members of a German statutory health insurance with inflammatory bowel diseases].
    Z Gastroenterol. 2016;54:139-45.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.